Salivary Iron And Ferritin Levels, Orofacial Complications of Patients With Thalassemia Major In Babylon Teaching Hospital For Maternity and Children

Mahdi Yakoob Kzar,Ali Mihsen Hussein
Authors Emails are requested on demand or by logging in
Keywords : Thalassemia, blood disorders, iron deposition, organ failure.
Medical Journal of Babylon  14:1 , 2017 doi:1812-156X-14-1
Published :17 July 2017


Different common known genetic disorders such as ?- thalassemia major; cause the oral and dental problems. Elevated levels or overload of ferritin and iron need continuous chelation to eliminate toxic effects on the body tissues. The purpose of this study to detect the salivary ferritin and iron levels and association with oral and maxillofacial abnormalities or complications in ?-thalassemia major. This study was done from January to march in 2017, thirty (30) patients with thalassemia type (?) major participated in pediatric and gynecology Babylon teaching hospital/department of hematology- hereditary blood disorders centers-sub branch (thalassemia), the examination procedures including (laboratory), intra and extra-orally views obtained foe each patients. Salivary analysis was highly significant (0.000) in salivary ferritin and iron levels in compared to controls. Different percentages of oral and perioral complications were appeared in those patients due to toxic effect of iron depositions.


Hemoglobinopathies is considering as other genetic disturbance[1]. Two alpha (?) and beta (?) chains are normally a tetramer of hemoglobin in adult persons; deficient synthesis of either the above ? or ? chains of globin in the molecules of hemoglobin lead to congenital disorder is called thalassemia in which the erythrocyte are an aberrant morphology with both microcytic and hypochromic [2]. The more severe congenital hemolytic anemia is ?-thalassemia major. Hemolysis is huge and iron overload is precipitate in different types in human body, hematocrit level decrease below than 20% and hemoglobin level can reach 2 to 3 g/dl [3-6]. Iron over load remains high, that lead to prevalence of multiple complications. The accumulations of iron in Beta thalassemia major patients is the sequel of defective erythropoiesis, elevated G.I.T absorption of iron, and loss of excreting mechanism of excess iron. About 250 mg of iron is the unit of transfused blood, while only about 1 mg of iron that the body excreted per day. If the iron binding capacity of transferrin present in the body plasma is consider highly toxic to the tissues as non-transferrin bound iron [7]. Dysfunction of heart, liver and endocrine glands are due to progressive accumulation of iron. Evaluation of iron loaded in Beta thalassemia major by measuring the serum ferritin level in the body [8, 9]. 1000 ng/1 (usually after 10th to 12th transfusion) level of serum ferritin, generally used as a point to begin iron chelation therapy. Ashen-gray color of the face because the mixing paller, hemosiderosis and jaundice. Cardiomegaly, hepatomegaly and splenomegaly are also notice in patients with thalassemia [10]. Oral and dental systems are affected, the main complications that appears in mouth, jaw and the face of thalassemia major. The preventing tooth structure from decay and therapeutic measures for control and reduce risk of infection whether dental or non-dental in origin, those seriously in these patients [11]. Level of ferritin in different body tissues is increases, due to lysis of red blood cells and lead to tissues and organs damage. Sedimentation of ferritin in salivary acini, will lead to salivary glands destructive and damage and dryness of the mouth, tooth decay as a consequences [12]. Dental and orofacial abnormalities include teeth spacing, saddle nose and protrusion of maxillary, molar bones, anterior open bite [13]. Expansion of marrow spaces are seen in radio graphical viewing, including the long bones as a cortical erosion rarefaction, nutrient foramina is enlarge and "raindrop" spaces in the cortex [14, 15]. As general taking in the jaws; the rarefaction in the alveolar bone, cortical bone is appear thin and a" chicken-wire" shape of the enlarge marrow spaces and lamina dura appear thin and premaxilla bone is thin and roots of the teeth are short in some cases [16]. Delayed pneumatization of the Para nasal sinuses. Because anemia and deposition of bilirubin pigment lead to lemon yellow or pale color of the oral mucosal surface [17]. Finally, defective globin chain structure, iron not related with hemoglobin inside the cells with increased iron in plasma lead to increase oxidative stress within thalassemia major patients. In these patients, periodontal diseases and chronic localized oral infections are appearing due to local and systemic immune with inflammatory response [18].

Materials and methods

 In this study was done for two months from January to march in 2017,  thirty (30) patients with thalassemia type (?) major inpediatric and gynecology Babylon teaching hospital / department of hematology- hereditary blood disorders-sub branch (thalassemia), the examination procedures including (laboratory), intra and extra-orally with dental diagnostic disposable instruments( mirror, probe, flash light and sterilized gauze).
Those patients were already diagnosed by hematology specialists in this center (pediatric and gynecology Babylon teaching hospital). The questionnaire was prepared and followed in each step of patient s examination. The patients with thalassemia majors were identical or matched in numbers and age ranges with control samples. Analysis of salivary iron by manual spectrophotometric method and salivary ferritin by Mini-vidus instrument. These patients that already compare with same numbers of controls persons with no signs and symptoms of any medical history.


In the beginning, the normal iron level = 50-180 mg/ dl for male and for female is 60-175 mg/dl, while the normal values for ferritin levels are: 10-160 mg/dl for male < 45 years and 68-430 mg/dl for female, with age range (4-20) years old and these normal values are used as stranded in body secretion. Thirty (30) patients with thalassemia type (?) major were taken without signs and symptoms of any other systemic diseases, Age of patients in this group is very important; because too low age ranges is less significant according to many previous researches such as Mohammed Shooriabi et al., March, 2016. Allthe saliva samples (about 2 ml of unstimulated state) were deep freezing at -20?c and store in clean sterile collections and analysis ways.


The thalassemia is one of the most health trouble that result from genetically distributed disease.?- thalassemia major, is life-limited event lead to chronic severe anemia, growth and development reduction, hypertrophy skeletal changes, endocrine disorders, erythriod expansion, infections tendencies and myocardium iron deposition lead as a consequences to heart failure [19, 20]. Thirty patients were included in this study; salivary analysis was appearing highly significant (0.000) in salivary ferritin and iron levels. Iron deposition and overload requires removal from the body; lead to the clinical manifestations and consequences, this idea is very important to explanations how this overload lead to different complications. Almost those patients were visiting the thalassemic centers to give all parameters for treatment; monitoring laboratory investigations and fallow up. One of these parameters to prevent iron overload, the chelators (Deferoxamine) in the form of intravenous bolus at the time of transfusion. Large numbers of thalassemia patients have elevated levels of salivary ferritin and irons due to tissues and organs deposition, contaminated transfusion with infection, improper chelation [10]. Goals of transfusions to suppression increased gut iron absorption, correct state of anemia and inhibition of erythropoiesis. Because; improper chelation and progressive load of irons, results in dysfunction of heart with cardiac hypertrophy and dilation, myocardial degeneration but in rare cases fibrosis will occur, liver (cirrhosis and fibrosis) and endocrine glands (as anterior pituitary defect will cause sexual maturation dysfunction and secondary amenorrhea) [21]. Most common noticed oral and perioral manifestations; Xerostomia and Halitosis (66.6%), Changes in oral mucosa (26.6%), Candidial infection (20%), and Enlarged of salivary glands (76.6%). Different forms of oral mucosal changes were appeared in oral cavity of patients with thalassemia major that significantly higher in those patients when compared to controls, these oral changes due to nutritional deficiencies such as; vitamin-B 12, folate and iron levels defects, also angular stomatitis was noticed; all above clinical and dental manifestations were associated with opportunistic infection as Candida albicans, because immunological abnormalities occurred [21]. Low socioeconomically levels, difficulties in transplantations, and improper managements in rural areas unfortunately; all above factors causes clinical findings and abnormalities in thalassemia patients were higher in rural areas than urban [23-25]. Increasing age and severity with worsening of disease as a accumulative factor and heavily depositions of irons and ferritin in serum and saliva leading to infiltration of serous cells, acinarin parotid and mixing cells in submandibular and other salivary glands will show xerostomia (dry mouth), enlargements or swellings of salivary glands, and halitosis as a sequel of dry mouth and due to improper oral hygiene [25].


Multiple signs and symptoms, with variety of complications in those patients that were suffered from thalassemia hemglobinopathies. Blood transfusion and chelation of iron are better option for managing ?-thalassemia major but not curative, these options have efficacy to reducing the risk of toxicity. Criteria for successful treatment of patients with thalassemia depend on proper diagnosis and managing plan including oral and systemic health. Regular blood and repeated infusion preserving hemoglobin levels at 10 mg/d with removal of iron load to prevent systemic, oral and perioral symptoms (including bones ,soft tissues). Degree of anemia and time of treatment beginning will reflect these abnormalities such as bone expansion and deformity, hyperactivity of marrow will compensate anemia. Early diagnosis and treatment leads to fewer complications.


1. Beutler E: Genetic disorders of human red blood cells. JAMA 233: 1187-1188, 1975.
2 . Malcolm A, Martin S Greeberg. Burket s oral medicine.9th ed. Philadelphia. Lippincott, pp. 534-39, 1994.
3. Longo, Braun wald, Antony S fuci, Kasper, Hauser, Jameson. Harrison s principle of internal medicine. 15th ed . New York, Me Grow Hill, pp. 666-74:2001.
4. Malcolm A, Martin S Greenberg. Burket s oral medicine. 9th. Philadelphia, Lippincott , pp.534-39:1994.
5. Farhud D, Sadighi H. Investigation of prevalence of beta thalassemia in Iranian provinces. Iran J Pub Health, 26:3-6:1997.
6. Miller. Blood disease in infancy childhood. 3rd ed. London, mosby, pp.280-340:1989.
7. Giardina PJ and grady RW. Chelation therapy in ?- thalassemia; An Optimistic Upate.Hematol, 38:360-366:2001.
8. Midiri M, Locasto A, Sparacia G, et al. MRI imaging of pancreatic changes in patients with transfusion dependent beta thalassemia major. Am J Roentgenol, 173(1): 187-192: 199.
9. Soliman AT, Elzalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion dependent children and aldolescents with thalassemia major and sickle cell diseases; a comparative study. J Trop Pediatr, 45(1):23-30: 1999.
10. Porter JB. Practical management of iron overload. Bri J hematol, 115:239-153: 2001.
11. Arabion HR, Farhadpoor A, Fijian S, Booeshagh A. Survey of oral and dental health status, periodontal and DMFT in Major Thalassemia patients Referred to Shahid Dastghid Hospital of Shiraz. Sadra Medical Sciences J 1(3):129-38: 2013.
12. Thein SL Pathophysiology of beta Thalassemia-A Guide to Molecular Therapies. The American Society of Hematology; 31-7: 2005.
13. Asl Amin Abadi N, Shirmohammadi A, Balayi E. Determination of carried condition in under treatment major thalassemic children in Tabriz Pediatric Hospital. J Dent Sch; 26(3):233-38: 2008.
14. Modell B, Berdoukas V: The clinical approach to thalassemia. New York, Grune and Stratton, pp, 53-75: 1984.
15. Lawson JP, Ablow RC, Pearson HA: The ribs in thalassemia. 1. The relationship to therapy. Radiology 140: 663-672:1981.
16. Poynton HG: Oral radiology, Baltimore, Williams and Wilkins, pp. 230-232:1982.
17. Margot L, Van Dis. The thalassemia: oral manifestations and complications. Oral Med, Oral Path Oral Surg, 62:229-33:1986.
18. D Aiuto F, Graziani F, Tete S, Gabriele M, Tonetti MS. Periodontitis: from local infection to systemic diseases. Int J Immunopathol Pharmacol 2005; 18:1-11:.
19. Weatherall JD, Clegg JB. The thalassemia syndromes (3rd edn). Oxford: Blackwell, pp, 1981; 132-74.
20. Modell B. Management of thalassemia major. Br Med Bull, 1976; 32: 270-6.
21. Abbott M., Galloway al. Infection with Iron Overload, Hemochromatosis presenting with a doubleyersinia infection. J infect, 1986; 13:143-5.
22. Oliveri NF. The ?- thalassemia. New Eng J of Med, 1999; 341:99-107.
23. Lynch M.A: Hematologic diseases, Diagnosis and treatment of Hematologic diseases, Burket s Oral Medicine, 7th ed, 1973; 203-409.
24. Sreebny L.M, Valdini A, Xerostomia Part I: Relationship to other symptoms and salivary gland hypofunction, O. Surg. O. Med. O. Pathol, 1988: 66-451.
25. Hattab FN, Hazza a AM, Yassin OM, al-RimawiHS. Caries risk in-patients with thalassemia major. Int DentJ, Feb,2001; 51: 35-8.
26. Goldfarb A, Nizan DW, Marmary Y, Changes in the parotid gland of beta thalassemia patients due to hemosiderin deposits. Int J Oral Surgery, 1983; 12:115-9.

The complete article is available as a PDF File that is freely accessible. The fully formatted HTML version can be viewed as HTML Page.

Medical Journal of Babylon

volume 14 : 1

Share |

Viewing Options

Download Abstract File
( 167 KB )

Related literature

Cited By
Google Blog Search
Other Articles by authors

Related articles/pages

On Google
On Google Scholar
On UOBabylon Rep

User Interaction

35  Users accessed this article in 1 year past
Last Access was at
23/09/2017 01:52:26